文献速递临床试验与 GCP

习惯训练与习惯训练联合直接视觉生物反馈治疗成人慢性便秘:随机对照试验研究方案

Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2017-03-24

这是一项三臂、平行分组、多中心随机对照试验,计划纳入394例18-70岁慢性便秘成人,按3:3:2随机分配至习惯训练、习惯训练联合计算机生物反馈、或经肛门直肠与结肠病理生理检查指导分配至前两臂之一。主要结局为治疗结束后6个月PAC-QOL评分较基线下降≥0.4分(量表的10%)的治疗反应。

要点

  • 比较习惯训练联合计算机直接视觉生物反馈与单独习惯训练在慢性便秘成人中的临床有效性。
  • 评估基于肛门直肠和结肠病理生理检查结果分层分配治疗是否改善结局。
  • 主要结局为治疗结束后6个月PAC-QOL评分下降≥0.4分(量表的10%)的治疗反应。

核心结论

  • 该试验有潜力回答慢性便秘管理中的一些主要未决问题,包括昂贵的侵入性检查是否有必要,以及计算机辅助直接视觉生物反馈是否比管理良好的专科建议带来额外获益。

研究设计与样本

  • 三臂、平行分组、多中心随机对照试验,计划纳入394例同意参与的成人慢性便秘患者,按3:3:2分配至习惯训练、习惯训练联合生物反馈、或经检查指导分配至前两臂之一,分析基于意向性治疗。

主要发现

  • 便秘影响高达20%的成人,慢性便秘影响1-2%的成人。
  • 近80%的患者认为泻药治疗不满意,症状对生活质量有显著影响。
  • 专科检查的价值以及使用生物反馈的设备密集型治疗相比专科保守建议是否带来额外获益尚不确定。

关键数值与推荐

  • 纳入标准:成人(18-70岁)慢性便秘,定义为自报症状持续时间超过6个月;既往泻药或促动力药以及饮食和生活方式调整失败。
  • 主要结局:治疗结束后6个月患者便秘生活质量评估(PAC-QOL)评分下降0.4分(量表的10%)或以上的治疗反应。
  • 其他结局随访至12个月,包括症状、生活质量、卫生经济学、心理健康和定性体验。
  • 假设1:在未选择的慢性便秘成人中,与单独习惯训练相比,习惯训练联合计算机辅助直接视觉生物反馈在6个月时使PAC-QOL评分平均降低0.4分。
  • 假设2:与未根据检查指导的治疗相比,根据病理生理检查结果分层分配至习惯训练或习惯训练联合生物反馈在6个月时使PAC-QOL评分平均降低0.4分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Constipation affects up to 20% of adults. Chronic constipation (CC) affects 1-2% of adults. Patient dissatisfaction is high; nearly 80% feel that laxative therapy is unsatisfactory and symptoms have significant impact on quality of life. There is uncertainty about the value of specialist investigations and whether equipment-intensive therapies using biofeedback confer additional benefit when compared with specialist conservative advice. METHODS/DESIGN: A three-arm, parallel-group, multicentre randomised controlled trial. OBJECTIVES: to determine whether standardised specialist-led habit training plus pelvic floor retraining using computerised biofeedback is more clinically effective than standardised specialist-led habit training alone; to determine whether outcomes are improved by stratification based on prior investigation of anorectal and colonic pathophysiology. Primary outcome measure is response to treatment, defined as a 0.4-point (10% of scale) or greater reduction in Patient Assessment of Constipation-Quality of Life (PAC-QOL) score 6 months after the end of treatment. Other outcomes up to 12 months include symptoms, quality of life, health economics, psychological health and qualitative experience. HYPOTHESES: (1) habit training (HT) with computer-assisted direct visual biofeedback (HTBF) results in an average reduction in PAC-QOL score of 0.4 points at 6 months compared to HT alone in unselected adults with CC, (2) stratification to either HT or HTBF informed by pathophysiological investigation (INVEST) results in an average 0.4-point reduction in PAC-QOL score at 6 months compared with treatment not directed by investigations (No-INVEST). Inclusion: chronic constipation in adults (aged 18-70 years) defined by self-reported symptom duration of more than 6 months; failure of previous laxatives or prokinetics and diet and lifestyle modifications. Consenting participants (n = 394) will be randomised to one of three arms in an allocation ratio of 3:3:2: [1] habit training, [2] habit training and biofeedback or [3] investigation-led allocation to one of these arms. Analysis will be on an intention-to-treat basis. DISCUSSION: This trial has the potential to answer some of the major outstanding questions in the management of chronic constipation, including whether costly invasive tests are warranted and whether computer-assisted direct visual biofeedback confers additional benefit to well-managed specialist advice alone. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number: ISRCTN11791740. Registered on 16 July 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Norton C, Emmanuel A, Stevens N, et al. Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: study protocol for a randomised controlled trial. Trials. 2017. PMID: 28340625. doi:10.1186/s13063-017-1880-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。